Skip to main content

HSBC HOLDINGS PLC

Position in GH — Guardant Health, Inc.

CIK 873630 LONDON, X0

Position in GH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$15,900,028
+$6,769,901 QoQ
Shares Held
105,979
+7.2% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#133
of 593 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GH Over Time

Shares Held

Position Value (USD)

Derivatives in GH

reported options exposure · as of Dec 31, 2021
CallValue
$210,042
CallShares
2,100
PutValue
$130,026
PutShares
1,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

HSBC HOLDINGS PLC holds $1,492,978,218 across 23 Diagnostics & Research names. GH ranks #13 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GH

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,900,028 105,979
2026-03-31 $9,130,127 98,843
2025-12-31 $863,184 8,451
2025-09-30 $356,635 5,708
2025-06-30 $2,708,265 52,042
2025-03-31 $801,391 18,812
2024-12-31 $580,785 19,011
2024-09-30 $347,494 15,148
2024-06-30 $2,014,264 69,746
2024-03-31 $1,901,405 92,167
2023-12-31 $1,177,540 43,532
2023-09-30 $513,987 17,341
2023-06-30 $1,455,270 40,650
2023-03-31 $396,698 16,924
2022-09-30 $1,048,877 19,485
2022-06-30 $786,024 19,485
2022-03-31 $1,352,355 20,416
2021-12-31 $210,042 2,100
2021-12-31 $1,512,402 15,121
2021-12-31 $130,026 1,300
2021-09-30 $1,561,749 12,493
2021-06-30 $1,979,712 15,941
2021-03-31 $1,070,075 7,010
2020-12-31 $1,778,285 13,798
2020-09-30 $256,199 2,292